TheraVasc
Cleveland, US · Founded 2009
Founders & leadership
AG
Anthony GiordanoExecutive
Board
KC
Kyle ChanBoard director
JH
John HustonBoard director
JZ
John ZakBoard director
SL
Susan LuriaBoard director
Reported raises · per SEC filings
Form D private placements$350K disclosed across 1 round · 2014
▶$350KraisedMar 2014 · 1 investors · PharmaceuticalsRule 506(b)
▶$350KraisedMar 2014 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kyle ChanDirector
- Anthony GiordanoExecutive Officer, Director
- John HustonDirector
- John ZakDirector
- Susan LuriaDirector
- Offering amount
- $2M
- Amount sold
- $350K
- Proceeds to insiders
- $110K
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware, 2009
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has TheraVasc raised?
- TheraVasc has disclosed $350K raised across 1 round.
- Where is TheraVasc headquartered?
- TheraVasc is headquartered in Cleveland, US.